ResMed Inc. (NYSE:RMD) will look for acquisitions. Chief Financial Officer, Brett Sandercock said, Going forward, we plan to continue to reinvest for growth through R&D. We also expect to continue to deploy capital for tuck-in acquisitions such as Citus Health and Ectosense, an acquisition we completed on October 1, 2021.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
194.7 USD | +2.82% |
|
+1.73% | +13.21% |
01/07 | ResMed Inc.(NYSE:RMD) added to Russell 1000 Dynamic Index | CI |
01/07 | ResMed Inc.(NYSE:RMD) added to Russell Midcap Value Index | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.21% | 28.61B | |
+1.75% | 206B | |
+3.42% | 177B | |
+31.54% | 157B | |
+32.16% | 112B | |
+1.71% | 64.63B | |
+21.08% | 55.63B | |
-1.61% | 47.57B | |
-9.11% | 36.87B | |
-0.34% | 35.18B |
- Stock Market
- Equities
- RMD Stock
- News ResMed, Inc.
- ResMed to Seek Acquisitions